EPIPEN Act
Latest Action
Referred to the Subcommittee on Health.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The EPIPEN Act (H.R. 6965) is a health-related bill introduced in the 118th Congress, originating in the House of Representatives. As of the latest update on December 17, 2024, the bill was referred to the Subcommittee on Health but has since failed or expired. The bill's official summary and full text are not available, limiting detailed analysis. The legislation falls under the health policy area, suggesting it addresses issues related to epinephrine auto-injectors (commonly known as EpiPens), which are critical for treating severe allergic reactions.
H.R. 6965, the EPIPEN Act, aimed to address health concerns related to epinephrine auto-injectors but did not advance beyond subcommittee referral and ultimately expired without enactment.
- The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
- No official summary or full text is publicly available, restricting detailed content analysis.
- The bill is categorized under the health policy area and is related to epinephrine auto-injectors.
['Individuals requiring epinephrine auto-injectors for severe allergic reactions', 'Healthcare providers involved in allergy treatment', 'Health agencies overseeing medication accessibility and safety']
['Lack of publicly available full text and summary limits understanding of implementation requirements and cost implications.', 'Without detailed provisions, oversight mechanisms and authority delegation cannot be assessed.', "The bill's failure to progress suggests potential challenges in legislative support or policy alignment."]
The EPIPEN Act was introduced in the 118th Congress and referred to the House Subcommittee on Health. The bill did not advance beyond this stage and expired, indicating it did not receive sufficient legislative action to become law. The absence of an official summary or full text in public records limits insight into the bill's specific legislative objectives or policy proposals.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['If enacted, the bill could have influenced the availability, affordability, or regulation of epinephrine auto-injectors, potentially affecting allergy treatment protocols.', 'Failure to pass may maintain the status quo in epinephrine auto-injector policy and market conditions.']
The absence of an official summary and full bill text limits transparency and public oversight. Tracking legislative progress shows the bill did not advance beyond subcommittee referral, highlighting the importance of monitoring early-stage bills for potential policy impacts. Future transparency efforts would benefit from ensuring full documentation is publicly accessible.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.